Indorama Ventures PCL ADR (INDOY)

Indorama Ventures PCL ADR is a depositary receipt listed on OTC Markets that represents common stock in Indorama Ventures Public Company Limited. The underlying issuer manufactures and distributes petrochemical products in Thailand, the United States, Brazil, and other international markets. Its operations are organized into four segments: Combined PET, Indovida, Indovinya, and Fibers. Combined PET covers the PET value chain, including paraxylene, purified terephthalic acid, PET, recycling, and related specialty chemicals. Indovida focuses on packaging, while Indovinya provides specialty chemical solutions for home and personal care, crop solutions, coatings, and energy and resources, as well as downstream surfactants. The Fibers segment produces polyester, rayon, nylon, polypropylene, composites, and worsted wool fibers for use in home, apparel, hygiene and medical, automotive, and industrial applications. The company, incorporated in 1994 and headquartered in Bangkok, Thailand, was formerly known as Beacon Global Limited and adopted its current name in March 2009.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-INDO.Y
$5.80
-17.5% Downside
Fair
Fair
May 6, 2026
June 8, 2026
0.15
2.2%
August 11, 2026
-14.1x
1.1x
0.3x
4.137 B
11.48 B
65.0%
32.5%
4.0
-54.7%
-299.7%
Valuation • Fair Value

Indorama Ventures PCL ADR (OTC-INDO.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for Indorama Ventures PCL ADR (OTC-INDO.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$5.80

Estimated downside of 17.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$5.16

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$6.44

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Indorama Ventures PCL ADR (OTC-INDO.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Indorama Ventures PCL ADR (OTC-INDO.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

13.568 B

Current operating scale indicator.

Revenue Forecast

14.767 B

Forward revenue estimate.

EBITDA

740.3 M

Current operating profitability reference.

EBITDA Forecast

1.388 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Indorama Ventures PCL ADR (OTC-INDO.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Indorama Ventures PCL ADR (OTC-INDO.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.96

No elevated caution signal from this screen.

Altman Z-Score

4.0

Relatively strong balance-sheet zone.

FCF / Net Income

-299.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Indorama Ventures PCL ADR (OTC-INDO.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Indorama Ventures PCL ADR (OTC-INDO.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 11, 2026

Days to Earnings

21

Dividend Payment Date

June 8, 2026

Ex-Dividend Date

May 6, 2026

Dividend Yield

2.2%

Income yield reference.

Upcoming Dividend

0.15

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

-54.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Indorama Ventures PCL ADR (OTC-INDO.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Indorama Ventures PCL ADR (OTC-INDO.Y) Stock Forecast & Technical Outlook

Review Indorama Ventures PCL ADR (OTC-INDO.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Not available

The 15-minute technical signal for Indorama Ventures PCL ADR (OTC-INDO.Y) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Not available

The 1-hour technical signal for Indorama Ventures PCL ADR (OTC-INDO.Y) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Indorama Ventures PCL ADR (OTC-INDO.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Indorama Ventures PCL ADR (OTC-INDO.Y) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Indorama Ventures PCL ADR (OTC-INDO.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Indorama Ventures PCL ADR (OTC-INDO.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Indorama Ventures PCL ADR (OTC-INDO.Y) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Indorama Ventures PCL ADR (OTC-INDO.Y) Stock FAQ

Quick answers about Indorama Ventures PCL ADR (OTC-INDO.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$5.80
Estimated downside 17.5%
Valuation Rating
Overvalued
Estimated downside of 17.5%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for Indorama Ventures PCL ADR (OTC-INDO.Y) is $5.80. This implies an estimated downside of 17.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 17.5% versus the current market price.

An analyst price target for Indorama Ventures PCL ADR (OTC-INDO.Y) is not currently available in the latest data file.

The current financial health read for Indorama Ventures PCL ADR (OTC-INDO.Y) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Indorama Ventures PCL ADR (OTC-INDO.Y) is August 11, 2026.

Based on the current data, dividend yield is 2.2%, upcoming dividend amount is 0.15, ex-dividend date is May 6, 2026, payment date is June 8, 2026.

The current P/E ratio listed for Indorama Ventures PCL ADR (OTC-INDO.Y) is -14.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Indorama Ventures PCL ADR is 4.137 B.

The current enterprise value listed for Indorama Ventures PCL ADR is 11.48 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Indorama Ventures PCL ADR is OTC-INDO.Y, and the stock is listed on OTC Markets.

Indorama Ventures PCL ADR (OTC-INDO.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Indorama Ventures PCL ADR is 65.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Indorama Ventures PCL ADR is 32.5%. Free float helps investors understand how much of the share base is available for public trading.